Episode Details

Back to Episodes
Resveratrol and fibrosis pathways in the filtering bleb

Resveratrol and fibrosis pathways in the filtering bleb

Published 4 months ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/resveratrol-and-fibrosis-pathways-in-the-filtering-bleb

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Resveratrol and Fibrotic Scarring after Glaucoma Surgery Glaucoma filtering surgery (trabeculectomy) lowers eye pressure by draining fluid through a small fistula under the conjunctiva. However, normal wound healing can overdo it – fibroblasts invade and transform into myofibroblasts, producing excess collagen and scar tissue. This scarring can plug the new drainage (filtering bleb), causing surgical failure. Surgeons often use anti-scarring drugs like mitomycin C, but these can have serious side effects. Resveratrol, a natural compound in grapes and berries, is known for antioxidant and anti-inflammatory effects. Emerging evidence suggests resveratrol may also dampen fibrotic signals in tissues. This article reviews how resveratrol might modify pathways (like SIRT1 and TGF-β) that drive fibrosis in ocular tissues, evaluates its human safety and dosing, and considers how to test it after trabeculectomy. We summarize what is known about resveratrol’s effects on key scarring processes and how it might be used to help preserve the filtering bleb. Fibrosis Pathways and Resveratrol’s Actions After trabeculectomy, injury to the conjunctiva triggers a cascade of healing steps: inflammation, tissue proliferation, and remodeling. Very early on, inflammatory cells release TGF-β (transforming growth factor beta), a potent growth factor that drives fibroblasts to proliferate and become myofibroblasts. These myofibroblasts produce a dense extracellular matrix (collagen, fibronectin, etc.) and express contractile proteins. In the eye, this scar plugs the bleb so that fluid no longer drains properly () (). In essence, a tightly balanced scarring response is needed for a safe bleb – too much scar widens bleb wall closure and bleb failure, while too little scar can cause leaks or hypotony. Thus, controlling but not completely blocking these pathways is the goal. Resveratrol can influence several molecular targets involved in fibrosis: SIRT1 activation: Resveratrol is known to activate Sirtuin 1 (SIRT1), an enzyme that regulates gene expression. SIRT1 acts like a brake on fibrosis. In skin and organ fibrosis models, boosting SIRT1 sharply reduced collagen production and myofibroblast markers (). One study of human skin cells showed that activating SIRT1 (similar to resveratrol’s effect) almost completely blocked TGF-β-driven collagen synthesis and myofibroblast formation (). In mice with induced skin fibrosis, a SIRT1 activator halted and even reversed scarring. In short, SIRT1 naturally restrains the TGF-β/Smad fibrotic program, and resveratrol’s SIRT1 activation may impart these anti-fibrotic benefits (). Inhibition of TGF-β/Smad signaling: (Transforming Growth Factor-β) is a key switch for fibrosis. When TGF-β binds receptors on fibroblasts, it activates Smad2/3 and SMAD4 proteins that move to the nucleus and turn on scar-making genes (collagen, fibronectin, alpha-smooth muscle actin). Resveratrol interferes with this cascade. In cultured trabecular meshwork cells, resveratrol reduced TGF-β1 levels and the activity of downstream Smad proteins (). It downregulated TGF-β1 and SMAD4 gene expression while upregulating the inhibitory SMAD7 (). Computer simulations suggest resveratrol binds with SMAD4’s MH2 domain, hindering the Smad complex from turning on fibrosis genes (). The result was dramatically lower production of collagens (type I

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us